Peripheral Blood Mononuclear Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, and Peripheral Blood Mononuclear Cell Isolation & Viability Kits), By Application (Immunology, Hematology, Infectious Disease, Hematology, and Others), By Techniques (Density Gradient Centrifugation, Leukapheresis, and Others), By Source (Human, Animals), By Region, Competition, Forecast and Opportunities

  • Industry : Healthcare
  • Pages : 168
  • Published Date : July, 2023
Customization Enquiry

Buy Now

Summary

Report Description

Global peripheral blood mononuclear cells market was valued at USD 235.68 million in 2022 and is anticipated to grow at a CAGR of 10.39%, during the period, 2023-2028 owing to rising rate in number of cell therapies, high demand of research and development for toxicology testing and reaction mechanism of the compound responsible for new and stable development of products. For instance, in June 2023, a study published in National Library of Medicine, it assessed the immune response of peripheral blood mononuclear cells (PBMC) that were infected in vitro with the Colombian strain (Col) of Trypanosoma cruzi and treated with Benzonidazole.

Peripheral blood mononuclear cells (PBMCs) are a type of blood cell that plays a crucial role in the immune system. PBMCs are a heterogeneous population of cells that are isolated from the peripheral blood, which is the blood circulating throughout the body. They are composed of lymphocytes, monocytes, and other immune cells. Lymphocytes are a type of white blood cell that includes T cells, B cells, and natural killer (NK) cells. T cells are responsible for cell-mediated immune responses, B cells produce antibodies for humoral immune responses, and NK cells are involved in the innate immune system and killing infected or cancerous cells. Monocytes are another type of white blood cell that circulate in the bloodstream and can differentiate into macrophages or dendritic cells when they migrate into tissues. Macrophages are responsible for engulfing and destroying foreign substances, dead cells, and cellular debris, while dendritic cells play a critical role in initiating and regulating immune responses by presenting antigens to T cells. The isolation and characterization of PBMCs have revolutionized the understanding of the immune system and have contributed to advancements in various fields, including cancer research, infectious diseases, autoimmune disorders, and transplantation medicine.

PBMCs are widely used in various research applications, including immunology, cell therapy, vaccine development, and drug discovery. They provide valuable insights into immune responses, allow researchers to study various immune cell populations, and serve as a source of cells for cell-based therapies. PBMCs can be isolated from peripheral blood using techniques such as density gradient centrifugation or specialized cell separation methods.

Additionally, the rise in number of cell therapies, expansion in research & development schemes, increasing focus of key players on R&D in peripheral blood mononuclear cells, increasing focus on regenerative medicine, as well as an increase in demand for cell operations among the population, increasing investigation of various aspects of immunology, infectious diseases, autoimmune disorders, transplantation, and vaccine development are projected to provide market players with lucrative prospects in the future.

Growing Advancement for Toxicology Research

The growing awareness of customer for peripheral blood mononuclear cells, as well as a growing preference for antibody development, are two important growth drivers for the industry. PBMC is crucial to carry out the biology and pathology related studies as well as in clinical research related to fatal diseases, immunology, vaccine development, etc. For instance, according to the clinicaltirals.gov.in, 972 studies are carried out for peripheral blood mononuclear cells. PBMCs provide information on the effects of prospective novel medication molecules on people, particularly on their immune systems. Drug toxicity that affects PBMCs can result in several serious, sometimes fatal toxic side effects, including immune system suppression and poisoning. Toxicology research aims to evaluate the potential harmful effects of chemical substances, drugs, and environmental factors on living organisms. PBMCs are used in immunotoxicity studies to assess the impact of these substances on the immune system. By exposing PBMCs to different compounds and analyzing immune responses, researchers can determine the immunotoxic effects, including alterations in immune cell populations, cytokine production, and immune function. The demand for PBMCs in immunotoxicity research is thus increasing, contributing to the growth of the global peripheral blood mononuclear cells market.

Increasing Importance of Peripheral Blood Mononuclear Cells for Cell Therapy

Patients now have a better alternative to cell-based therapies with respect to traditional regenerative medicines, but their side effects have hindered its use among customers. In this product category, developed regions such as North America and Europe have a strong presence of cell therapies for human well-being. Population is gaining awareness regarding the use of peripheral blood mononuclear cells in cell and gene therapy. Hence, the extraction and usage of peripheral blood mononuclear cells prove to be the key driving force for market expansion. However, the fatal diseases such as acute myocardial infarction, chronic heart failure, spinal cord injury, stroke, and wound healing have all been successfully treated in pre-clinical studies using the secretome of apoptotic peripheral blood mononuclear cells which drives the market growth globally. For instance, according to the Centers for Disease Control and Prevention, around 37,300 new cases of HPV+ tumour occurs each year in the U.S., accounting for 3% of all malignancies in women and 2% of all cancers in men. With increasing prevalence of HPV in the country, companies are continuously focusing on the development of therapy and drugs to enter the US market. PBMCs serve as a valuable source of immune cells for cell therapy. They contain various types of immune cells, including T cells, B cells, and natural killer (NK) cells, which play crucial roles in immune responses and disease targeting. PBMCs provide a diverse population of immune cells that can be isolated, manipulated, and utilized in different cell therapy approaches.

Also, the Adoptive Cell Transfer (ACT) is a type of cell therapy that involves the transfer of immune cells, typically T cells, into patients to target and eliminate diseases, such as cancers. PBMCs are often used as a starting material to isolate and expand specific subsets of T cells, such as tumor-infiltrating lymphocytes (TILs), tumor-associated antigen-specific T cells, or genetically engineered T cells. PBMCs provide a convenient source of T cells for ACT therapies.


Download Free Sample Report

Growing Investment in Research & Development for Human Well-Being

Rapid advancements in research and development (R&D) practices and activities are propelling the growth of the market as novel cell/gene therapies/medications and new products are developed for the treatment of fatal diseases. PBMCs are a reasonable way to acquire physiologically relevant (immune) proteins from routinely collected blood samples, and they do so without the native human plasma's well-known analytical challenges brought on by the presence of highly abundant proteins for driving the growth of the market. Furthermore, the government of different countries for their growth in healthcare sector are providing funds for the ongoing research of peripheral blood mononuclear cells.

Additionally, the growing awareness of the potential of PBMCs in disease research has led to increased R&D activities and contribute to market growth. PBMCs play a crucial role in drug discovery and development. They are utilized in early-stage research to assess the efficacy and safety of potential drug candidates. PBMCs provide a human-relevant model for studying immune responses and evaluating the effects of new compounds on immune cells. The growing awareness of the value of PBMCs in drug discovery has resulted in increased demand and utilization of these cells, driving the growth of the PBMCs market. The awareness of the therapeutic potential of cell-based therapies has been growing rapidly. PBMCs are essential in the development and manufacturing of cell-based therapies, such as adoptive cell transfer, CAR-T cell therapy, and immunotherapies. The therapeutic benefits of these advanced therapies, coupled with the increasing awareness of PBMCs' role in their development, have led to significant R&D efforts and the growth of global peripheral blood mononuclear cells market. There has been a notable increase in collaboration between academic institutions, research organizations, and the biopharmaceutical industry. This collaboration has fostered knowledge exchange, joint research projects, and funding initiatives focused on the application of PBMCs in various areas of research. The growing awareness of the potential of PBMCs and the collaborative efforts in R&D have positively impacted the growth of global peripheral blood mononuclear cells market.

Market Segmentation

The global peripheral blood mononuclear cells market is segmented based on product, application, technique, source, region, and competitive landscape. Based on product, the market can be split into cryopreserved or frozen PBMC cultured or fresh PBMC, and peripheral blood mononuclear cell isolation & viability kits. Based on application, the market can be divided into immunology, hematology, infectious disease, and others. Based on techniques, the market is divided into density gradient centrifugation, leukapheresis, and others. In terms of source, the market can be categorized into human and animals.

Company Profiles

Charles River Laboratories International, Inc., Lonza Group AG, Corning Inc, Bio-Rad Laboratories Inc, ABCAM, Biolegend Inc, ZEN-Bio Inc, DAPCEL, Inc., Creative Bioarray, iXCells Biotechnologies USA, LLC, Miltenyi Biotec B.V. & CO. KG, STEMCELL Technologies Inc., Precision Medicine Group, LLC, StemExpress, LLC, RayBiotech Life, Inc., REPROCELL Inc., Cytologics LLC, BioIVT LLC, Biopredic International, and Cell Applications, Inc. etc. are among the major players in the global peripheral blood mononuclear cells market.

Attribute

Details

Market size value in FY2022

USD 235.68 Million

Revenue Forecast in FY2028

USD 420.98 Million

Growth Rate

10.39%

Base Year

2022

Historical Years

2018 – 2028

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

Product

Application

Technique

Source

Regional Scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Key Companies Profiled

Charles River Laboratories International, Inc., Lonza Group AG, Corning Inc, Bio-Rad Laboratories Inc, ABCAM, Biolegend Inc, ZEN-Bio Inc, DAPCEL, Inc., Creative Bioarray, iXCells Biotechnologies USA, LLC, Miltenyi Biotec B.V. & CO. KG, STEMCELL Technologies Inc., Precision Medicine Group, LLC, StemExpress, LLC, RayBiotech Life, Inc., REPROCELL Inc., Cytologics LLC, BioIVT LLC, Biopredic International, Cell Applications, Inc.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)


Report Scope:

In this report, Global Peripheral Blood Mononuclear Cells Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Peripheral Blood Mononuclear Cells Market, By Product:
    • Cryopreserved or Frozen PBMC
    • Cultured or Fresh PBMC
    • Others
  • Peripheral Blood Mononuclear Cells Market, By Application:
    • Immunology
    • Hematology
    • Infectious Disease
    • Others
  • Peripheral Blood Mononuclear Cells Market, By Techniques:
    • Density Gradient Centrifugation
    • Leukapheresis
    • Others
  • Peripheral Blood Mononuclear Cells Market, By Source:
    • Human
    • Animal
  • Peripheral Blood Mononuclear Cells Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Singapore
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • UAE
      • Saudi Arabia
      • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global peripheral blood mononuclear cells market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Peripheral Blood Mononuclear Cells Market

5.    Voice of Customer

5.1.  By Type of Product

5.2.  By Type of Technique

5.3.  Type of Application for Which PBMCs Are Used

5.4.  Factors Driving Market Growth

6.    Global Peripheral Blood Mononuclear Cells Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC and Peripheral Blood Mononuclear Cell Isolation & Viability Kits)

6.2.2.     By Application (Immunology, Infectious Disease, Hematology and Others)

6.2.3.     By Technique (Density Gradient Centrifugation Process and Leukapheresis)

6.2.4.     By Source (Human and Animals)

6.2.5.     By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

6.2.6.     By Company (2021)

6.3.  Market Map

6.3.1.     By Product

6.3.2.     By Application

6.3.3.     By Technique

6.3.4.     By Source

6.3.5.     By Region

7.    North America Peripheral Blood Mononuclear Cells Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product

7.2.2.     By Application

7.2.3.     By Technique

7.2.4.     By Source

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Peripheral Blood Mononuclear Cells Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Application

7.3.1.2.3.             By Technique

7.3.1.2.4.             By Source

7.3.2.     Canada Peripheral Blood Mononuclear Cells Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Application

7.3.2.2.3.             By Technique

7.3.2.2.4.             By Source

7.3.3.     Mexico Peripheral Blood Mononuclear Cells Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Application

7.3.3.2.3.             By Technique

7.3.3.2.4.             By Source

8.    Europe Peripheral Blood Mononuclear Cells Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Application

8.2.3.     By Technique

8.2.4.     By Source

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     Germany Peripheral Blood Mononuclear Cells Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Application

8.3.1.2.3.             By Technique

8.3.1.2.4.             By Source

8.3.2.     France Peripheral Blood Mononuclear Cells Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Application

8.3.2.2.3.             By Technique

8.3.2.2.4.             By Source

8.3.3.     United Kingdom Peripheral Blood Mononuclear Cells Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Application

8.3.3.2.3.             By Technique

8.3.3.2.4.             By Source

8.3.4.     Italy Peripheral Blood Mononuclear Cells Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Product

8.3.4.2.2.             By Application

8.3.4.2.3.             By Technique

8.3.4.2.4.             By Source

8.3.5.     Spain Peripheral Blood Mononuclear Cells Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Product

8.3.5.2.2.             By Application

8.3.5.2.3.             By Technique

8.3.5.2.4.             By Source

9.    Asia-Pacific Peripheral Blood Mononuclear Cells Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Product

9.2.2.     By Application

9.2.3.     By Technique

9.2.4.     By Source

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Peripheral Blood Mononuclear Cells Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product

9.3.1.2.2.             By Application

9.3.1.2.3.             By Technique

9.3.1.2.4.             By Source

9.3.2.     Japan Peripheral Blood Mononuclear Cells Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product

9.3.2.2.2.             By Application

9.3.2.2.3.             By Technique

9.3.2.2.4.             By Source

9.3.3.     India Peripheral Blood Mononuclear Cells Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product

9.3.3.2.2.             By Application

9.3.3.2.3.             By Technique

9.3.3.2.4.             By Source

9.3.4.     South Korea Peripheral Blood Mononuclear Cells Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Product

9.3.4.2.2.             By Application

9.3.4.2.3.             By Technique

9.3.4.2.4.             By Source

9.3.5.     Australia Peripheral Blood Mononuclear Cells Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Product

9.3.5.2.2.             By Application

9.3.5.2.3.             By Technique

9.3.5.2.4.             By Source

10.  South America Peripheral Blood Mononuclear Cells Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Product

10.2.2.  By Application

10.2.3.  By Technique

10.2.4.  By Source

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Peripheral Blood Mononuclear Cells Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product

10.3.1.2.2.           By Application

10.3.1.2.3.           By Technique

10.3.1.2.4.           By Source

10.3.2.  Argentina Peripheral Blood Mononuclear Cells Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product

10.3.2.2.2.           By Application

10.3.2.2.3.           By Technique

10.3.2.2.4.           By Source

10.3.3.  Colombia Peripheral Blood Mononuclear Cells Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product

10.3.3.2.2.           By Application

10.3.3.2.3.           By Technique

10.3.3.2.4.           By Source

11.  Middle East and Africa Peripheral Blood Mononuclear Cells Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Product

11.2.2.  By Application

11.2.3.  By Technique

11.2.4.  By Source

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  UAE Peripheral Blood Mononuclear Cells Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Product

11.3.1.2.2.           By Application

11.3.1.2.3.           By Technique

11.3.1.2.4.           By Source

11.3.2.  Saudi Arabia Peripheral Blood Mononuclear Cells Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Product

11.3.2.2.2.           By Application

11.3.2.2.3.           By Technique

11.3.2.2.4.           By Source

11.3.3.  South Africa Peripheral Blood Mononuclear Cells Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Product

11.3.3.2.2.           By Application

11.3.3.2.3.           By Technique

11.3.3.2.4.           By Source

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Clinical Trial Analysis

14.1.              Ongoing Clinical Trials

14.2.              Completed Clinical Trials

14.3.              Terminated Clinical Trials

14.4.              Breakdown of Pipeline, By Development Phase

14.5.              Breakdown of Pipeline, By Status

14.6.              Breakdown of Pipeline, By Study Type

14.7.              Breakdown of Pipeline, By Region

14.8.              Clinical Trials Heat Map

15.  Competitive Landscape

15.1.              Competitive Outlook

15.2.              Company Profiles

15.2.1.  Charles River Laboratories International, Inc.

15.2.2.  Lonza Group AG

15.2.3.  Corning Inc

15.2.4.  Bio-Rad Laboratories Inc

15.2.5.  ABCAM

15.2.6.  Biolegend Inc

15.2.7.  ZEN-Bio Inc

15.2.8.  DAPCEL, Inc.

15.2.9.  Creative Bioarray

15.2.10.                iXCells Biotechnologies USA, LLC

15.2.11.                Miltenyi Biotec B.V. & CO. KG

15.2.12.                STEMCELL Technologies Inc.

15.2.13.                Precision Medicine Group, LLC.

15.2.14.                StemExpress, LLC

15.2.15.                RayBiotech Life, Inc.

15.2.16.                REPROCELL Inc.

15.2.17.                Cytologics LLC

15.2.18.                BioIVT LLC

15.2.19.                Biopredic International

15.2.20.                Cell Applications, Inc.

16.  Strategic Recommendations

17.  TechSci Research – Awards and Recognition

18.  About Us & Disclaimer

Figures and Tables

Figure 1:               Global Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 2:               Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 3:               Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application Type, By Value, 2018-2028F

Figure 4:               Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 5:               Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 6:               Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Region, By Value, 2018-2028F

Figure 7:               Global Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Company, By Value, 2022

Figure 8:               Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Product, Market Size (USD Billion) & Growth Rate (%), 2022

Figure 9:               Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Application, Market Size (USD Billion) & Growth Rate (%), 2022

Figure 10:            Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Technique, Market Size (USD Billion) & Growth Rate (%), 2022

Figure 11:            Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Source, By Type, Market Size (USD Billion) & Growth Rate (%), 2022

Figure 12:            Global Peripheral Blood Mononuclear Cells Market (PBMCs) Map, By Region, Market Size (USD Billion) & Growth Rate (%), 2022

Figure 13:            North America Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 14:            North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 15:            North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 16:            North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 17:            North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 18:            North America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F

Figure 19:            United States Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 20:            United States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 21:            United States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 22:            United States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 23:            United States Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 24:            Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 25:            Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 26:            Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 27:            Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 28:            Canada Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 29:            Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 30:            Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 31:            Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 32:            Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 33:            Mexico Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 34:            Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 35:            Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 36:            Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 37:            Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 38:            Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 39:            Europe Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F

Figure 40:            Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 41:            Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 42:            Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 43:            Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 44:            Germany Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 45:            France Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 46:            France Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 47:            France Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 48:            France Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 49:            France Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 50:            United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 51:            United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 52:            United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 53:            United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 54:            United Kingdom Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 55:            Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 56:            Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 57:            Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 58:            Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 59:            Italy Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 60:            Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 61:            Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 62:            Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 63:            Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 64:            Spain Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 65:            Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 66:            Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 67:            Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 68:            Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 69:            Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 70:            Asia Pacific Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F

Figure 71:            China Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 72:            China Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 73:            China Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 74:            China Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 75:            China Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 76:            Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 77:            Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 78:            Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 79:            Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 80:            Japan Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 81:            India Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 82:            India Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 83:            India Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 84:            India Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 85:            India Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 86:            South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 87:            South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 88:            South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 89:            South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 90:            South Korea Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 91:            Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 92:            Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 93:            Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 94:            Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 95:            Australia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 96:            Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 97:            Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 98:            Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 99:            Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 100:          Singapore Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 101:          Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 102:          Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 103:          Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 104:          Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 105:          Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 106:          Middle East & Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F

Figure 107:          UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 108:          UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 109:          UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 110:          UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 111:          UAE Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 112:          Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 113:          Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 114:          Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 115:          Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 116:          Saudi Arabia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 117:          South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 118:          South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 119:          South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 120:          South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 121:          South Africa Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 122:          South America Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 123:          South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 124:          South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 125:          South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 126:          South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 127:          South America Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Country, By Value, 2018-2028F

Figure 128:          Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 129:          Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 130:          Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 131:          Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 132:          Brazil Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 133:          Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 134:          Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 135:          Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 136:          Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 137:          Argentina Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 138:          Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Size, By Value (USD Billion), 2018-2028F

Figure 139:          Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Product, By Value, 2018-2028F

Figure 140:          Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Application, By Value, 2018-2028F

Figure 141:          Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Technique, By Value, 2018-2028F

Figure 142:          Colombia Peripheral Blood Mononuclear Cells Market (PBMCs) Share, By Source, By Type, By Value, 2018-2028F

Figure 143:          Global Percentage of Cell and Gene Therapy Clinical Trials as of 2019, Divided by Clinical Trial Phase

Figure 144:          Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Development Phase, 1992-2023

Figure 145:          Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Status, 1992-2023

Figure 146:          Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Study Type, 1992-2023

Figure 147:          Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Region, 1992-2023

Figure 148:          Peripheral Blood Mononuclear Cells: Breakdown of Pipeline, By Year, 2017-2023

Figure 149:          Peripheral Blood Mononuclear Cells: Clinical Trials Heat Map


Table 1:           Global Cancer Statistics, 2020

Table 2:           Total Number of New Cancer Cases and Deaths Reported Globally, By Type, 2020

Table 3:           North America Cancer Statistics, 2020

Table 4:           Total Number of New Cancer Cases and Deaths Reported in North America, By Type, 2020

Table 5:           Europe Cancer Statistics, 2020

Table 6:           Total Number of New Cancer Cases and Deaths Reported in Europe, By Type, 2020

Table 7:           Asia Pacific Cancer Statistics, 2020

Table 8:           Total Number of New Cancer Cases and Deaths Reported in Asia Pacific, By Type, 2020

Table 9:           Middle East & Africa Cancer Statistics, 2020

Table 10:         Total Number of New Cancer Cases and Deaths Reported in Middle East & Africa, By Type, 2020

Table 11:         South America Cancer Statistics, 2020

Table 12:         Total Number of New Cancer Cases and Deaths Reported in South America, By Type, 2020

Table 13:         Pricing Analysis of PBMC Products

Table 14:         Clinical Trial Analysis

Frequently asked questions

down-arrow

Global Blood Peripheral Cells market is expected to grow at a steady rate of 10.39% and reach USD 420.98 million by 2028 on account of increasing numbers of cell therapies and rising innovative ideas for research and development.

down-arrow

North America region holds the largest share for peripheral blood mononuclear cells market with a CAGR of 10.90% due to the rising research in the field of toxicology.

down-arrow

Charles River Laboratories International, Inc., Lonza Group AG, Corning Inc, Bio-Rad Laboratories Inc., Abcam, etc. are the leading market players of global peripheral blood cells market in the forecast period, 2024-2028.

down-arrow

Increased number of cell therapies for human well-being and growing use of PBMCs in toxicology research are boosting the global peripheral blood mononuclear cells market in the forecast years of 2024-2028.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Peripheral Blood Mononuclear Cells Market to Grow with a CAGR of 10.39% through 2028

Jul, 2023

Increased number of cell therapies for human well-being is expected to drive the growth of global peripheral blood mononuclear cells market in the forecast period.

Why Choose Us